Profil
Jennifer Zibuda worked as a Director of Investor Relations & Communications at Prothena Corp.
Plc from 2020 to 2023.
Prior to that, she worked as an Investor Relations Contact at Portola Pharmaceuticals, Inc. and as the Head of Corporate Communications at Alkermes Plc.
Ehemalige bekannte Positionen von Jennifer Zibuda
| Unternehmen | Position | Ende |
|---|---|---|
| PROTHENA CORPORATION PLC | Investor Relations Contact | 01.01.2023 |
| ALKERMES PLC | Public Communications Contact | 01.06.2018 |
| PORTOLA PHARMACEUTICALS, INC. | Investor Relations Contact | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| PROTHENA CORPORATION PLC | Health Technology |
| ALKERMES PLC | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Portola Pharmaceuticals LLC
 Portola Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Portola Pharmaceuticals, Inc. engaged in the development and commercialization of novel therapeutics in the areas of thrombosis, other hematologic disorders, and inflammation. It offers Andexxa and Bevyxxa medicines. The company was founded by Charles J. Homcy and David R. Philips on September 2, 2003 and is headquartered in South San Francisco, CA. | Health Technology |
